Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Rivaroxaban versus enoxaparin prophylaxis in postpartum women requiring anticoagulation
MOH_2018-05-23_000472Phase 2Not yet recruiting
- Sponsor
- ד"ר יוסף קליש
- Start
- Aug 2017
- Modality
- Recombinant Proteins and Enzymes, Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, open-label trial in venous thromboembolism (VTE) comparing Standard treatment with Clexane with Investigational treatment with Xarelto (2 arms). Primary endpoint: Efficacy comparison of prophylactic anticoagulation. Planned start Aug 2017; status: not yet recruiting.
02
Drugs
rivaroxabanenoxaparin
03
Conditions
venous thromboembolism (VTE)
Beyond the preview
Go deeper on MOH_2018-05-23_000472.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on MOH_2018-05-23_000472.